No significant role for beta tubulin mutations and mismatch repair defects in ovarian cancer resistance to paclitaxel/cisplatin

Overview of attention for article published in BMC Cancer, August 2005

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (71st percentile)
Above-average Attention Score compared to outputs of the same age and source (52nd percentile)

Mentioned by

patent: 1 patent

wikipedia: 2 Wikipedia pages

Citations

dimensions_citation: 31 Dimensions

Readers on

mendeley: 25 Mendeley

Summary Patents Wikipedia Dimensions citations

So far, Altmetric has seen 1 patent that references this research output.

BIOMARKERS FOR TREATMENT WITH ANTI-TUBULIN CHEMOTHERAPEUTIC COMPOUNDS

Application WO-2013130093-A1

World Intellectual Property Organisation (WIPO)

This page shows the most recent patents that mention this research output.

Click here to find out how to access more activity.